Secondary Central Nervous System Lymphoma (SCNSL)
4 clinical trials · Condition
◉ Watch Secondary Central Nervous System Lymphoma (SCNSL)
| Record | Firm | Date |
|---|---|---|
| A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies (NCT05131022) | Nurix Therapeutics, Inc. | 2022-04-13 |
| Ibrutinib With Rituximab and Lenalidomide for Patients With Recurrent/Refractory Primary or Secondary Central Nervous System Lymphoma (PCNSL/SCNSL) (NCT03703167) | Memorial Sloan Kettering Cancer Center | 2019-01-22 |
Track Secondary Central Nervous System Lymphoma (SCNSL) automatically
Every clearance here is in the API, with alerts when new ones post.